E-LIB Suche - Ergebnisse für: Nagaraja, Raj

1

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor ..:

Konteatis, Zenon ; Travins, Jeremy ; Gross, Stefan...
Journal of Medicinal Chemistry. 64 (2021) 8 - p. 4430-4449 , 2021

Link: https://doi.org/10.1021/..

2

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dua..:

Konteatis, Zenon ; Artin, Erin ; Nicolay, Brandon...
ACS Medicinal Chemistry Letters. 11 (2020) 2 - p. 101-107 , 2020

Link: https://doi.org/10.1021/..

3

Effect of Mild and Moderate Hepatic Impairment on the Pharm..:

Fan, Bin ; Dai, David ; Cohen, Marvin...
Clinical Pharmacology in Drug Development. 10 (2020) 1 - p. 99-109 , 2020

Link: https://doi.org/10.1002/..

4

Preclinical toxicology profile of squalene epoxidase inhibi..:

Nagaraja, Raj ; Olaharski, Andrew ; Narayanaswamy, Rohini...
Toxicology and Applied Pharmacology. 401 (2020) - p. 115103 , 2020

Link: https://doi.org/10.1016/..

5

EXTH-34. COMBINED USE OF THE PAN-IDH MUTANT INHIBITOR AG-88..:

Nicolay, Brandon ; Narayanaswamy, Rohini ; Amatangelo, Michael D...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi79-vi79 , 2017

Link: https://doi.org/10.1093/..

6

EXTH-59. THE IDH1 MUTANT INHIBITOR AG-120 SHOWS STRONG INHI..:

Nicolay, Brandon ; Narayanaswamy, Rohini ; Aguado, Elia...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi86-vi86 , 2017

Link: https://doi.org/10.1093/..

7

Exploration of cathepsin S inhibitors characterized by a tr..:

Moss, Neil ; Xiong, Zhaoming ; Burke, Mike...
Bioorganic & Medicinal Chemistry Letters. 22 (2012) 23 - p. 7189-7193 , 2012

Link: https://doi.org/10.1016/..

8

A new class of 5-HT2B antagonists possesses favorable poten..:

Moss, Neil ; Choi, Younggi ; Cogan, Derek...
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 8 - p. 2206-2210 , 2009

Link: https://doi.org/10.1016/..

9

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dua..:

Konteatis, Zenon ; Artin, Erin ; Nicolay, Brandon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025383/. , 2020

Link: http://www.ncbi.nlm.nih...

10

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensi..:

McKenney, Anna Sophia ; Lau, Allison N ; Somasundara, Amritha Varshini Hanasoge...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159958/. , 2018

Link: http://www.ncbi.nlm.nih...

11

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensi..:

McKenney, Anna Sophia ; Lau, Allison N ; Somasundara, Amritha Varshini Hanasoge...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785272/. , 2018

Link: http://www.ncbi.nlm.nih...

12

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensi..:

McKenney, Anna Sophia ; Somasundara, Amritha Varshini Hanasoge ; Spitzer, Barbara...
http://dx.doi.org/10.1172/JCI94516. , 2018

Link: http://hdl.handle.net/17..

13

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor ..:

Zenon Konteatis (2236249) ; Jeremy Travins (4810641) ; Stefan Gross (673951)...
https://figshare.com/articles/journal_contribution/Discovery_of_AG-270_a_First-in-Class_Oral_MAT2A_Inhibitor_for_the_Treatment_of_Tumors_with_Homozygous_i_MTAP_i_Deletion/14387567. , 2021

Link: https://doi.org/10.1021/..

14

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor ..:

Zenon Konteatis (2236249) ; Jeremy Travins (4810641) ; Stefan Gross (673951)...
https://figshare.com/articles/dataset/Discovery_of_AG-270_a_First-in-Class_Oral_MAT2A_Inhibitor_for_the_Treatment_of_Tumors_with_Homozygous_i_MTAP_i_Deletion/14387570. , 2021

Link: https://doi.org/10.1021/..

15

An Investigation about Microstructures, Mechanical Properti..:

Raj, N. Mohan ; Kumar, N. Mathan ; Nagaraja, S..
Key Engineering Materials. 979 (2024) - p. 93-102 , 2024

Link: https://doi.org/10.4028/..